Overview
- 32 inspections across 32 sites are on record.
- 11 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-24.
At a glance
Inspections
32
Sites
32
Observations
11
Career since
Feb 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Christopher R. DeFilippi, MD | 24 Apr 2026 | Medical Devices & Rad Health | |
| Alejandra M.L. Romeo | 20 Mar 2026 | Human Drugs | On file |
| Dr. Juan Manuel Puig | 13 Mar 2026 | Human Drugs | |
| Itshac Itsik Ben-Dor, M.D. | 19 Feb 2026 | Medical Devices & Rad Health | |
| AstraZeneca Pharmaceuticals LP | 14 Jan 2026 | Human Drugs |
Sites inspected
Christopher R. DeFilippi, MDFalls Church, United States1 insp.
Alejandra M.L. RomeoCiudad Autonoma Buenos Aires, Argentina1 insp.
Dr. Juan Manuel PuigSan Juan, Argentina1 insp.
Itshac Itsik Ben-Dor, M.D.Washington, United States1 insp.
AstraZeneca Pharmaceuticals LPGaithersburg, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
David L Chon8 shared
Kerun Hardeo1 shared
Robin R Waller1 shared
Omadevi Somai1 shared
Koffi A Amegadje1 shared
Jonathan D Green1 shared
Gabrielle J Swain1 shared
Full investigator report
Get the verbatim findings behind Lucilla Facchin's 11 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site